Dr. Lin studies RNA biology, with a particular focus on long noncoding RNAs (lncRNAs). Over the past decade, he has applied bulk and single-cell RNA sequencing along with functional genomics to investigate the cellular origins of ovarian cancer and to identify noncoding regulatory elements that drive cancer initiation and progression. His representative publications include papers in Nature Genetics, Nature Communications, Cell Reports, iScience, and RNA Biology. His teaching interests at DKU include Biology, Experimental Molecular Biology, and Biochemistry.

His current research centers on two major directions: (1) elucidating the functions and mechanisms of lncRNAs in both physiology and disease, with a particular interest in the oncogenic lncRNA UCA1; and (2) developing RNA-centric technologies to identify lncRNA-binding partners.

Lin has a B.E. in Biological Engineering from Kunming University of Science and Technology and a Ph.D. in Microbiology from Institut Pasteur of Shanghai, Chinese Academy of Sciences. He obtained postdoctoral trainings in RNA Biology and Cancer Genomics at the University of California, Los Angeles and Cedars-Sinai Medical Center. Before joining Duke Kunshan University, he was a Project Scientist at Cedars-Sinai Medical Center.